The BUBBLEBOT project aims at the development of therapeutic micro bubbles incorporating magnetic particles that enable the precise delivery of therapeutic assets over a given area. These microbubbles incorporating magnetic particles will be studied as an innovative therapeutic tool in the treatment of glioblastoma, the most common form of cancer tumours in the brain. BUBBLEBOT is a project that draws on the expertise of the PRISME laboratory in magnetic guidance, the CBM laboratory for its expertise in therapeutic microbulles, the INEM laboratory for its expertise in neurotoxicity and the VERMON company specialized in medical imaging.
Emplois crées : 1
Action de communication : 4
Emplois crées : 3
Project leader
Member partner
No member partner
CBM CENTRE DE BIOPHYSIQUE MOLÉCULAIRE
LABORATOIRE INEM IMMUNOLOGIE ET NEUROGÉNÉTIQUE EXPÉRIMENTALES ET MOLÉCULAIRE
Start of the project on26 / 03 / 2025
Strategic business lines
Électronique : matériaux, composants et sous-systèmes
Referent of the project
Daniel MELEY
07 86 53 38 70
daniel.meley@s2e2.fr
Centre-Val de Loire
